Literature DB >> 3428007

Ciprofloxacin penetration in pancreatic juice.

P Pederzoli1, M Falconi, C Bassi, S Vesentini, F Orcalli, F Scaglione, M Solbiati, A Messori, N Martini.   

Abstract

The penetration of ciprofloxacin in pancreatic juice was investigated in 5 patients with pancreatic fistula. The drug was administered as a single oral dose of 500 mg after which serial samples of pancreatic juice and serum were collected for ciprofloxacin assay. The following pharmacokinetic parameters (mean +/- SD) were estimated from the serum level versus time curves: clearance 11.51 +/- 2.85 (ml/min/kg); Vd area 3.08 +/- 1.20 ml/kg; terminal half-life 3.10 +/- 0.92 h; mean residence time 5.64 +/- 1.40 h. Ciprofloxacin serum levels declined rapidly after the third hour, whereas concentrations in pancreatic juice remained elevated (above 1 mg/1) for nearly 12 h. The pancreatic juice/serum ciprofloxacin concentration ratio increased gradually fom 0.63 +/- 0.45 after 0.5 h to 6.18 +/- 4.59 after 12 h (mean +/- SD). Our data indicate that while the drug elimination half-life from the serum is short, the time-course of ciprofloxacin levels in the pancreatic juice conforms to a much slower disappearance rate. In particular, the ciprofloxacin levels achieved in pancreatic juice are constantly greater than the MICs of the bacteria generally responsible for pancreatic infections.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3428007     DOI: 10.1159/000238527

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  6 in total

1.  II. The Endocrine and Pancreatic Unit at the University of Verona, Italy.

Authors:  A A Gumbs
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

2.  Antimicrobial activity of human pancreatic juice and its interaction with antibiotics.

Authors:  E B Minelli; A Benini; C Bassi; H Abbas; M Falconi; F Locatelli; R de Marco; P Pederzoli
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

3.  Penetration of ciprofloxacin into the human pancreas.

Authors:  R Isenmann; H Friess; P Schlegel; K Fleischer; M W Büchler
Journal:  Infection       Date:  1994 Sep-Oct       Impact factor: 3.553

4.  Behavior of antibiotics during human necrotizing pancreatitis.

Authors:  C Bassi; P Pederzoli; S Vesentini; M Falconi; A Bonora; H Abbas; A Benini; E M Bertazzoni
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

Review 5.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

6.  The penetration of antibiotics into human pancreas.

Authors:  M Büchler; P Malfertheiner; H Friess; R Bittner; E Vanek; P Schlegel; H G Beger
Journal:  Infection       Date:  1989 Jan-Feb       Impact factor: 3.553

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.